PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA
It was performed the evaluation of the clinical efficacy of taurine in the treatment of postinfarction cardiosclerosis (PIC). 57 patients (mean age 60,2 ± 14,3 years) with evidence of PIC and angina. When incorporated into standard therapy taurine showed a statistically significant improvement (comp...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2016-06-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/533 |
| _version_ | 1797883816631599104 |
|---|---|
| author | V. V. Rezvan I. S. Vasilyeva N. V. Strizhova D. L. Vinogradov |
| author_facet | V. V. Rezvan I. S. Vasilyeva N. V. Strizhova D. L. Vinogradov |
| author_sort | V. V. Rezvan |
| collection | DOAJ |
| description | It was performed the evaluation of the clinical efficacy of taurine in the treatment of postinfarction cardiosclerosis (PIC). 57 patients (mean age 60,2 ± 14,3 years) with evidence of PIC and angina. When incorporated into standard therapy taurine showed a statistically significant improvement (compared to placebo) subjective performance status patients, normalize echocardiographic indices (increase of the ejection fraction) and laboratory parameters (reducing the concentration of total cholesterol, triglycerides, low density lipoprotein). The changes revealed clinical and instrumental parameters are stored for 3 months after receiving taurine. It is recommended to add taurine in a daily dose of 750 mg to standard therapy in patients with postinfarction cardiosclerosis with a view to its potentiating effect by improving the metabolic processes in the myocardium. |
| first_indexed | 2024-04-10T03:57:46Z |
| format | Article |
| id | doaj.art-ef54c31d32ec4b3da51a996b9a429992 |
| institution | Directory Open Access Journal |
| issn | 2226-6704 2411-6564 |
| language | Russian |
| last_indexed | 2024-04-10T03:57:46Z |
| publishDate | 2016-06-01 |
| publisher | SINAPS LLC |
| record_format | Article |
| series | Архивъ внутренней медицины |
| spelling | doaj.art-ef54c31d32ec4b3da51a996b9a4299922023-03-13T07:12:07ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642016-06-0163475210.20514/2226-6704-2016-6-3-47-52522PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINAV. V. Rezvan0I. S. Vasilyeva1N. V. Strizhova2D. L. Vinogradov3ГБОУ ВПО «Первый московский государственный медицинский университет им. И.М. Сеченова»ГБОУ ВПО «Первый московский государственный медицинский университет им. И.М. Сеченова»ГБОУ ВПО «Первый московский государственный медицинский университет им. И.М. Сеченова»ГБОУ ВПО «Первый московский государственный медицинский университет им. И.М. Сеченова»It was performed the evaluation of the clinical efficacy of taurine in the treatment of postinfarction cardiosclerosis (PIC). 57 patients (mean age 60,2 ± 14,3 years) with evidence of PIC and angina. When incorporated into standard therapy taurine showed a statistically significant improvement (compared to placebo) subjective performance status patients, normalize echocardiographic indices (increase of the ejection fraction) and laboratory parameters (reducing the concentration of total cholesterol, triglycerides, low density lipoprotein). The changes revealed clinical and instrumental parameters are stored for 3 months after receiving taurine. It is recommended to add taurine in a daily dose of 750 mg to standard therapy in patients with postinfarction cardiosclerosis with a view to its potentiating effect by improving the metabolic processes in the myocardium.https://www.medarhive.ru/jour/article/view/533ишемическая болезнь сердцапостинфарктный кардиосклерозтауринлипидный профильэхокардиография |
| spellingShingle | V. V. Rezvan I. S. Vasilyeva N. V. Strizhova D. L. Vinogradov PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA Архивъ внутренней медицины ишемическая болезнь сердца постинфарктный кардиосклероз таурин липидный профиль эхокардиография |
| title | PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA |
| title_full | PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA |
| title_fullStr | PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA |
| title_full_unstemmed | PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA |
| title_short | PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA |
| title_sort | prospects domestic drugs dibikor taurine in patients with myocardial infarction and stable angina |
| topic | ишемическая болезнь сердца постинфарктный кардиосклероз таурин липидный профиль эхокардиография |
| url | https://www.medarhive.ru/jour/article/view/533 |
| work_keys_str_mv | AT vvrezvan prospectsdomesticdrugsdibikortaurineinpatientswithmyocardialinfarctionandstableangina AT isvasilyeva prospectsdomesticdrugsdibikortaurineinpatientswithmyocardialinfarctionandstableangina AT nvstrizhova prospectsdomesticdrugsdibikortaurineinpatientswithmyocardialinfarctionandstableangina AT dlvinogradov prospectsdomesticdrugsdibikortaurineinpatientswithmyocardialinfarctionandstableangina |